Patents by Inventor Marc Benhamou

Marc Benhamou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monovalent ligand of the Fc?RI receptor as an anti-inflammatory agent
    Patent number: 7892538
    Abstract: The invention relates to the use of a monovalent antibody fragment directed against the EC2 domain of the Fc?RI receptor for the treatment of inflammatory diseases.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: February 22, 2011
    Assignee: Institut National de la Sante Et de la Recherche
    Inventors: Renato Monteiro, Benoît Pasquier, Ulrich Blank, Marc Benhamou, Pierre Launay, Marina Pretolani
  • Monovalent ligand of the Fcalphari Receptor as an Anti-Inflammatory Agent
    Publication number: 20080085280
    Abstract: The invention relates to the use of a monovalent antibody fragment directed against the EC2 domain of the Fc?RI receptor for the treatment of inflammatory diseases.
    Type: Application
    Filed: March 4, 2005
    Publication date: April 10, 2008
    Inventors: Renato Monteiro, Benoit Pasquier, Ulrich Blank, Marc Benhamou, Pierre Launay, Marina Pretolani